Recordati Industria Chimica e Farmaceutica SPA (RECN) Income Statement
Recordati Industria Chimica e Farmaceutica SPA Income Statement
Last quarter (Q2 2026), Recordati Industria Chimica e Farmaceutica SPA's total revenue was $697.36M, an increase of 8.30% from the same quarter last year. In Q2, Recordati Industria Chimica e Farmaceutica SPA's net income was $116.61M. See Recordati Industria Chimica e Farmaceutica SPA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 2.62B | $ 2.34B | $ 2.08B | $ 1.85B | $ 1.58B | |
| $ 1.79B | $ 1.60B | $ 1.42B | $ 1.29B | $ 1.15B | |
| $ 1.07B | $ 961.41M | $ 856.86M | $ 792.26M | $ 647.03M | |
| Depreciation and Amortization | $ 206.44M | $ 167.03M | $ 142.67M | $ 125.76M | $ 97.58M |
| $ 887.00M | $ 795.37M | $ 708.16M | $ 559.35M | $ 578.35M | |
| $ 719.74M | $ 638.90M | $ 558.01M | $ 437.33M | $ 490.19M | |
| $ -138.47M | $ -91.72M | $ -66.97M | $ -35.89M | $ -26.84M | |
| $ 581.27M | $ 547.18M | $ 491.04M | $ 401.44M | $ 463.35M | |
| $ 443.62M | $ 416.51M | $ 389.21M | $ 312.34M | $ 385.97M | |
| Per Share Metrics | |||||
| Basic EPS | $ 2.16 | $ 2.02 | $ 1.89 | $ 1.52 | $ 1.87 |
| Diluted EPS | $ 2.12 | $ 1.99 | $ 1.86 | $ 1.49 | $ 1.85 |
| Weighted Average Shares Outstanding | 205.48M | 206.32M | 205.63M | 205.58M | 206.01M |
| Weighted Average Shares Outstanding (Diluted) | 209.16M | 209.09M | 209.14M | 209.06M | 209.08M |
Currency in EUR
